It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...